5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone 99.0% white powder HRD

Zhuhai Hairuide Biological Technology Co., Ltd., established in February 2009, is a modern enterprise mainly engaged in R&D, production and sales of chemical raw materials, pharmaceutical intermediates, health foods, biological reagents, and cosmetics. The company's production base Located in Sanzao Technology Industrial Park, Jinwan District, Zhuhai City. The company's main products are pharmaceutical and chemical raw materials such as the side chain, main ring, mother core, intermediates and crude products of carbapenem antibiotics such as imipenem and biapenem. At the same time, the company also produces doxylamine succinate , Carbisamin maleate, triprolidine hydrochloride and other pharmaceutical and chemical products. Since its inception, the company has always adhered to the "development and production of cutting-edge pharmaceutical and chemical intermediates" as its development goal. Adhere to the business philosophy of "pursuing excellent product quality and reasonable low cost, and striving to create maximum value for customers to achieve a win-win situation", based on advanced scientific research and production technology, relying on high-quality products, and ensuring high-quality and efficient after-sale technical services To provide a win-win situation for investment managers. At the same time, the company follows the laws of the market, constantly improves the company's management and product production processes, and is committed to creating its own unique production and management system. The company has a standardized production base and high-quality professional production, management and marketing talents. Hairuide Biotechnology will rely on the superior advance awareness of decision-making level, strong financial strength, high-quality professional talents, high-quality and efficient services and all The active and professional dedication of employees, and in the attitude of being socially responsible, continue to march towards excellent national pharmaceutical industry enterprises.